FGF21 and myopathy: Irisin, BDNF, FGF-21, and probably osteonectin are the most promising biomarkers of HF-related myopathy and cachexia, while their role in the prediction of adverse cardiac remodeling and poor outcomes requires to be elucidated in the future.